Search results
Found 21924 matches for
Established in March 2020, the RECOVERY trial tests a range of potential treatments for COVID-19, including azithromycin, a widely used antibiotic that also reduces inflammation. The azithromycin arm of the trial was established to determine whether or not the drug has a meaningful benefit among patients hospitalised with COVID-19. A preliminary analysis shows no significant difference in the primary endpoint of 28-day mortality; there was also no evidence of beneficial effects on the risk of progression to mechanical ventilation or length of hospital stay.
Richard Maude
MBChB BSc DTM&H DPhil MD FRGS FRCP FRSPH Richard Maude - Professor of Tropical Medicine
Vitalija Skarbaliute Da Silva
Vitalija Skarbaliute Da Silva - Research Grants Manager/Deputy Business Manager
Mayfong Mayxay
Mayfong Mayxay - President of the Lao University of Health Sciences, Ministry of Health
Proochista Ariana
- MSc IHTM Lecturers
- MSc IHTM advisory committee
- MSc IHTM steering committee
- MSc MGH Lecturers
- Principal Investigators
- Research Scientists
Proochista Ariana - Associate Professor
